CorMedix Inc. | TalkMarkets | Page 1
No data available
No data available

Latest Articles

About This Stock More About This Stock
CRMD Announces FDA IND Filing For Neutrolin; ZFGN Completes Enrollment Of Phase 2a Trial Of Beloranib
Article By: BioMedReports
Friday, September 26, 2014 6:58 AM EDT
CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious disease.
In this article: CRMD, ZFGN
Read

Latest Tweets for $CRMD

No tweets yet!

PARTNER HEADLINES